يعرض 1,601 - 1,620 نتائج من 9,330 نتيجة بحث عن 'significantly ((((((less decrease) OR (we decrease))) OR (teer decrease))) OR (mean decrease))', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1601
  2. 1602

    Fig 5 - حسب Maha Rehman (17114332)

    منشور في 2025
  3. 1603

    Fig 4 - حسب Maha Rehman (17114332)

    منشور في 2025
  4. 1604

    This is the raw data used for this study. حسب James M. Friedman (22522150)

    منشور في 2025
    "…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …"
  5. 1605

    Pre-operative versus post-operative symptoms. حسب James M. Friedman (22522150)

    منشور في 2025
    "…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …"
  6. 1606

    Patient Demographics. حسب James M. Friedman (22522150)

    منشور في 2025
    "…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …"
  7. 1607

    Diagnostic Criteria for Human Disharmony Loop. حسب James M. Friedman (22522150)

    منشور في 2025
    "…Average age was 48. 37% were male. 89% of patients who received a preoperative subcoracoid injection reported a significant decrease in presenting symptoms. 6 months after PM release, median VAS pain scores decreased from 8 to 2. …"
  8. 1608

    Correlation between age and telomere age (TMA). حسب Chul-young Bae (14709766)

    منشور في 2025
    "…<div><p>Telomere length is a known indicator of biological aging, typically decreasing with age. Biological age is a benchmark for assessing an individual’s health and aging. …"
  9. 1609

    Effects of CGA on renal biochemical markers. حسب Liping Bao (2936715)

    منشور في 2025
    "…The results show that the level of serum creatinine (Scr), blood urea nitrogen (BUN), and urinary protein excretion in diabetic rats were significantly decreased after CGA intervention. CGA administration can active the Nrf2 pathway and inhibit NLRP3 inflammasome activation. …"
  10. 1610

    S1 Raw data - حسب Dominic Michael Rasp (19959412)

    منشور في 2024
    "…Compared to pre-match values, hamstring strength was significantly decreased after 15 and 30 minutes of simulated soccer match for the non-dominant and dominant leg, respectively. …"
  11. 1611

    S2 Raw data - حسب Dominic Michael Rasp (19959412)

    منشور في 2024
    "…Compared to pre-match values, hamstring strength was significantly decreased after 15 and 30 minutes of simulated soccer match for the non-dominant and dominant leg, respectively. …"
  12. 1612

    Summary of HSS and LSI during the LIST. حسب Dominic Michael Rasp (19959412)

    منشور في 2024
    "…Compared to pre-match values, hamstring strength was significantly decreased after 15 and 30 minutes of simulated soccer match for the non-dominant and dominant leg, respectively. …"
  13. 1613

    Baseline characteristics of the study sample<sup>β</sup>μ. حسب Osama Mohamed Ibrahim (12006954)

    منشور في 2024
    "…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"
  14. 1614

    The flow diagram of the study (CONSORT, 2010). حسب Osama Mohamed Ibrahim (12006954)

    منشور في 2024
    "…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …"
  15. 1615
  16. 1616
  17. 1617
  18. 1618
  19. 1619
  20. 1620